[Atrial fibrillation and adherence to guidelines in the real world: myth or reality?].
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia with a prevalence increasing with the aging of the population. AF has become a public health problem in general clinical practice. Despite the conclusive evidence of numerous randomized trials and publication of unified guidelines, their application in the real-world is often sub-optimal, in particular concerning the anticoagulation prescription. Most of these reports have focused on hospitalized patients or were performed by generalists, whereas in the real-world AF is managed in an out-of-hospital setting with growing implication of cardiologists. The purpose of this presentation is to demonstrate that a strict adherence to international guidelines can be obtained in the real-world of AF management. However, some improvements are needed to get an optimal use of anticoagulation.
Département de cardiologie, Hôpital de la Tour, Av.J.-D. Maillard Ibis, 1217 Meyrin. almex@bluemail.ch
A
A
Meiltz
M
M
Zimmermann
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000517:prevention & control*; D019983:Guideline Adherence; D006801:Humans; D017410:Practice Guidelines as Topic
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants